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The involvement of sodium/potassium-ATPase in regulating
parathyroid hormone (PTH) secretion is inferred from in vitro
studies. Recently, the a-klotho-dependent rapid recruitment
of this ATPase to the parathyroid cell plasma membrane in
response to low extracellular calcium ion was suggested to
be linked to increased hormone secretion. In this study, we
used an in vivo rat model to determine the importance of
sodium/potassium-ATPase in PTH secretion. Glands were
exposed and treated in situ with vehicle or ouabain, a specific
inhibitor of sodium/potassium-ATPase. PTH secretion was
significantly increased in response to ethylene glycol
tetraacetic acid-induced acute hypocalcemia and to the same
extent in both vehicle and ouabain groups. The glands were
removed, and inhibition of the ATPase was measured by
86rubidium uptake, which was found to be significantly
decreased in ouabain-treated parathyroid glands, indicating
inhibition of the ATPase. As ouabain induced systemic
hyperkalemia, the effect of high potassium on hormone
secretion was also examined but was found to have no effect.
Thus, inhibition of the parathyroid gland sodium/potassium-
ATPase activity in vivo had no effect on the secretory
response to acute hypocalcemia. Hence, the suggested
importance of this ATPase in the regulation of PTH secretion
could not be confirmed in this in vivo model.
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An enzyme system responsible for active transport across the
cell membrane was first identified in 1957 by Skou1,2 and
named Naþ - and Kþ -activated ATPase or Naþ ,Kþ -ATPase.
The Naþ ,Kþ -ATPase or Naþ pump is a protein
responsible for the active transport or pumping of Naþ
and Kþ ions across the plasma membrane, keeping a low
concentration of Naþ and a high level of Kþ within the cell.
The Naþ ,Kþ -ATPase is expressed in all mammalian cells. It
uses energy derived from hydrolysis of adenosine tripho-
sphate to the transport of Naþ and Kþ across the plasma
membrane with a stoichiometry of 3:2. The Naþ and Kþ
gradients create the electrical gradient across the plasma
membrane, which facilitates cell volume regulation, sodium-
coupled entry of ions, amino acids, glucose, and other
compounds, for example, the transcellular transport pro-
cesses in the intestine, exocrine glands, and kidneys.3,4
Furthermore, the Naþ ,Kþ -ATPase might function as a
signal transducer.5,6
Many cell types regulate cytosolic calcium concentration,
in part, through a Naþ /Ca2þ counter-transporter. In this
system, the sodium gradient created by the Naþ ,Kþ -ATPase
is used to transport calcium ions out of the cell.
In parathyroid cells, in contrast to most other secretory
cells,7–9 an increase in cytosolic calcium concentration is
associated with an inhibition rather than a stimulation of
parathyroid hormone (PTH) release.10,11
Brown et al.12,13 suggested that the Naþ ,Kþ -ATPase had a
role in the secretion of PTH as they observed that ouabain, a
specific inhibitor of the Naþ ,Kþ -ATPase, and low extra-
cellular potassium inhibited PTH secretion in vitro from
bovine parathyroid cells. Dispersed bovine parathyroid cells
contained abundant binding sites for ouabain. Inhibition of
PTH secretion by ouabain was associated with a concomitant
increase in cellular sodium and a reduction in cellular
potassium. Brown et al.13 tested the hypothesis that low Kþ
and ouabain might modulate PTH release through an
increase in cytosolic Ca2þ , which was related to alterations
in the Naþ–Ca2þ exchange. However, ouabain and low
extracellular potassium caused no significant increase in
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cytosolic Ca2þ concentrations in parathyroid cells. In
contrast, low Kþ caused a decrease in cytosolic Ca2þ at
high extracellular calcium, whereas ouabain decreased
cytosolic Ca2þ significantly at all examined Ca2þ concen-
trations from 0.5 to 2.0mmol/l.13
Thus, it has remained an open question, how Naþ ,Kþ -
ATPase activity influences parathyroid function. Recently,
Imura et al.14 proposed a novel mechanism linking a-klotho
activity and recruitment the of Naþ ,Kþ -ATPase to the cell
surface of the parathyroid cell and thereby to Ca2þ -regulated
PTH secretion.
Klotho is a type 1 membrane protein with similarity to
b-glucuronidase.15 It is predominantly expressed in the
kidney, choroid plexus, and parathyroid glands. An impor-
tant function of klotho in the kidney and possibly also in the
parathyroid glands is that of an obligatory co-receptor for
fibroblast growth factor 23.16,17 Fibroblast growth factor 23 is
a bone-derived hormone that in the kidney suppresses renal
phosphate reabsorption and synthesis of calcitriol and in
the parathyroids suppresses PTH synthesis and secretion.
In addition, an extracellular domain of the klotho protein
is shed into the systemic circulation and functions as an
endocrine factor.16,17
Imura et al. observed in vitro in parathyroid tissues
obtained from mice that the Naþ ,Kþ -ATPase was quickly
recruited, at low extracellular calcium, to the plasma
membrane in connection with the secretion of a-klotho.
This pathway was disrupted either by a-klotho deficiency or
by administration of ouabain. There was no significant effect
of ouabain on Ca2þ -sensitive PTH secretion from a-klotho/
glands. Therefore, it was suggested that a-klotho might be
required for Naþ ,Kþ -ATPase-dependent PTH release.14
Secondary hyperparathyroidism in uremia is characterized
by increased PTH-secretory response to hypocalcemia.18
We have previously shown an increased parathyroid
expression of klotho and Naþ ,Kþ -ATPase in severe hyper-
parathyroidism, secondary to uremia and hyperphos-
phatemia in the rat.19 Therefore, the aim of this investigation
was to examine the importance of parathyroid Naþ ,Kþ -
ATPase activity on Ca2þ -regulated PTH secretion in vivo
in the rat.
RESULTS
The in vivo effect of ouabain (2 and 10mmol/l) on low
Ca2þ -stimulated PTH secretion was examined. The para-
thyroid glands were exposed and treated in situ with ouabain,
a specific inhibitor of the Naþ ,Kþ -ATPase (2mmol/l) or
vehicle for 45min before and further for 1 h during the
following ethylene glycol tetraacetic acid (EGTA) infusion.
As inbred rats were used, the parathyroid glands had identical
size of 1mm3 (data not shown). Significant acute hypo-
calcemia was induced by an intravenous infusion of EGTA
(Po0.001), with no difference in plasma Ca2þ between
the two groups. As shown in Figure 1a, plasma PTH
increased significantly (Po0.001) to the same extent in both
vehicle- and ouabain-treated rats.
Similar results were obtained when the parathyroid glands
were treated in situ with 10mmol/l of ouabain or vehicle for a
longer period of time, that is, 120min before and further
during the following 50min of EGTA infusion, as shown in
Figure 1c and d. Significant acute hypocalcemia was induced
(Po0.001), with no difference in plasma Ca2þ between
the two groups, and plasma PTH increased significantly
(Po0.001) to the same extent in both vehicle- and ouabain-
treated rats.
To ensure that the Naþ ,Kþ -ATPase pump in the present
in vivo model was inhibited by ouabain, the parathyroid
glands were examined for 86Rubidium (86Rb) uptake. On the
basis of the fact that Naþ ,Kþ -ATPase transports 86Rb
similarly to potassium, 86Rb uptake by the parathyroid
glands was used as an index of Naþ ,Kþ -ATPase-mediated
active sodium–potassium transport. The parathyroid glands,
exposed in situ to either 10mmol/l ouabain or vehicle, were
removed and incubated separately for 30min in a Krebs–-
Ringer bicarbonate solution, containing 1.0 mCi/ml 86Rb. As
shown in Figure 2, 86Rb uptake was significantly decreased in
ouabain-treated compared to vehicle-treated parathyroid
glands (Po0.001), indicating that Naþ ,Kþ -ATPase activity
was inhibited in the ouabain group.
As shown in Figure 3, ouabain applied at a high
concentration (10mmol/l) to the parathyroid glands had a
clear systemic effect, inducing a significant increase in plasma
Kþ (Po0.001) and a significant decrease in plasma Naþ
(Po0.001).
Therefore, the effect of potassium in vivo on low Ca2þ -
stimulated PTH secretion was studied by an intravenous
infusion of 300mmol/l KCl as compared with the effect of
isotonic NaCl. As shown in Figure 4, plasma Kþ levels were
significantly increased (Po0.001) by KCl infusion, with the
high plasma Kþ having no significant effect on the PTH-
secretory response to low Ca2þ . At the time of the peak Kþ
level (after 30min of KCl infusion), the Ca2þ level was
slightly lower and the PTH level slightly stimulated before the
start of the EGTA infusion. However, this difference was not
statistically significant.
DISCUSSION
Exposure of rat parathyroid glands in vivo to high
concentrations of ouabain, the specific inhibitor of
Naþ ,Kþ -ATPase activity, had no effect on PTH secretion
in this experimental model.
No parathyroid cell line is available for the study of
PTH secretion. This impedes the possibilities for studying
parathyroid cell function. Previous studies describing an
effect of ouabain on PTH secretion were all performed in
in vitro models of dispersed bovine parathyroid cells or
mouse thyroparathyroids.12–14,20 It is well known that
parathyroid cells loose their phenotype very fast in in vitro
systems.21–24 Therefore, we decided to use an in vivo
model with in situ treatment of the parathyroid glands. A
similar model has previously been described by Silver and
colleagues.25
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We pretreated the parathyroids with ouabain for 2 h before
inducing hypocalcemia, and then ouabain treatment was
continued for another hour during an EGTA infusion. This
long-term treatment was based on the observation made by
Brown et al.12 that the in vitro kinetics for the association of
ouabain with bovine parathyroid cells was relatively slow and
that equilibrium was approached after 2–3 h. Interestingly,
Imura et al.14 performed short-time incubations of 30min,
and an inhibitory effect of ouabain was seen already after
10min on mouse parathyroids in vitro.
In the present in vivo rat model, the stimulating effect of
low Ca2þ on PTH secretion was neither impaired after a
short term (5–50min) of ouabain treatment (data not shown)
nor after longer time exposure (170min). Furthermore, no
effect of ouabain on PTH secretion was observed after
120min exposure to normocalcemia, despite a significant
systemic effect resulting in hyperkalemia and an almost
equimolar decrease in plasma sodium. Rothstein et al.20 used
an in vitro model of dispersed bovine parathyroid cells and
found that PTH release was inhibited by ouabain at 0.5mmol/l
calcium, but not at 1.0 or 3.0mmol/l calcium. In the study
by Brown et al.,12 an inhibitory effect of ouabain was seen at
both 0.6 and 1.0mmol/l calcium, but not at 2.0mmol/l.
Imura et al.14 examined the effect of ouabain only at a low
Ca2þ concentration of 0.5mmol/l. As such, because of these
previous in vitro results and the potential impact of
inhibition of Naþ ,Kþ -ATPase activity on Naþ–Ca2þ
exchange in the parathyroid cell, this investigation was
designed to focus on a hypocalcemic range of plasma Ca2þ
concentrations. A continuous infusion of EGTA induced a
reduction in plasma Ca2þ to a very low level of 0.65mmol/l.
No effect of ouabain was observed in a large spectrum of
plasma Ca2þ levels, from normal levels of 1.30 to profound
hypocalcemia of 0.65mmol/l. We used EGTA, a calcium
chelator, as Brown et al.12 have shown that EGTA did not
prevent the inhibitory effect of ouabain on PTH secretion.
In a group of rats, in which a high concentration of
10mmol/l ouabain was applied on the parathyroids, a
systemic effect of ouabain was seen with rats developing
significant hyperkalemia. As Kþ might activate the
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Figure 1 | Effect of ouabain, 2 and 10mmol/l, on low Ca2þ -stimulated PTH secretion in vivo. (a) The parathyroid glands were exposed
and treated in situ with ouabain (2mmol/l), a specific inhibitor of the Naþ ,Kþ -ATPase, or vehicle for 45min before and for another
60min during an intravenous EGTA infusion. (b) Significant acute hypocalcemia was induced by the infusion of EGTA (30mmol/l, at a rate of
3.0ml/h; Po0.001), with no difference in plasma Ca2þ between the two groups. Plasma PTH increased significantly (Po0.001) to the
same extent in both vehicle- and ouabain-treated rats (panel a). (c) The parathyroid glands were then exposed and treated in situ with
ouabain (10mmol/l) or vehicle for 120min before and for another 50min during the EGTA infusion. (d) Significant acute hypocalcemia was
induced (Po0.001), with no difference in plasma Ca2þ between the two groups. Plasma PTH increased significantly (Po0.001) to the
same extent in both vehicle- and ouabain-treated rats (panel c). Mean±s.e.m., n¼ 19 in each group. EGTA, ethylene glycol tetraacetic acid;
PTH, parathyroid hormone.
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Naþ ,Kþ -ATPase from the extracellular site,1 a model of
hyperkalemic rats was created to examine whether the high
levels of Kþ by itself would influence PTH secretion. The
levels of plasma Kþ were comparable with the high levels
seen in uremic patients. However, hyperkalemia had no effect
on low calcium-stimulated PTH secretion.
Brown et al.26 previously examined the effect of potassium
on PTH secretion from bovine parathyroid cells. They found
that removal of extracellular potassium markedly inhibited
PTH secretion at low calcium in a dose-related manner,
whereas no effect of increasing potassium above 2–3mmol/l
was seen.26 In another study, Shobac and Brown27 compared
the effect of 5–60mmol/l potassium concentration and found
that PTH release was stimulated by 60mmol/l Kþ . Such an
extreme extracellular potassium concentration is of no
relevance for an in vivo model. However, potassium ions
were shown to reduce the efficacy of the Naþ ,Kþ -ATPase for
ouabain, predominantly through a reduction in the associa-
tion rate.28
Therefore, in the present model, the effective inhibition of
Naþ ,Kþ -ATPase activity in the parathyroids was tested by
measuring 86Rb uptake by the parathyroid glands.29 86Rb
uptake was significantly inhibited by ouabain exposure in this
in vivo model.
The concentrations of ouabain used in the present
investigation and in the paper by Imura et al.14 were very
high. Imura et al. observed an effect of 1mmol/l ouabain on
mice parathyroids in an in vitro model. In the present
investigation, we used a concentration of 2mmol/l of
topically applied ouabain for exposure to the parathyroids,
as a local external application potentially is less effective, than
exposure through the medium to cells in vitro.
As no effect of ouabain was observed at a concentration of
2mmol/l, a much higher concentration of 10mmol/l was
used. Still, no effect on the PTH-secretory response to
hypocalcemia was observed, despite the fact that a clear
systemic effect of ouabain was obtained.
The Naþ ,Kþ -ATPase is a large protein complex. The
minimum functional unit is a heterodimer of a- and
b-subunits. Individual genes of four a-subunit isoforms and
at least three b-subunit isoforms of the Naþ ,Kþ -ATPase have
been identified in mammals. The isoforms combine to form a
number of Naþ ,Kþ -ATPase isozymes that are expressed in a
tissue- and cell-specific manner. The specific regulation of
the expression of these isozymes in rat parathyroids is out of
the scope of this investigation. In most mammalian species,
the Naþ ,Kþ -ATPase, irrespective of isoform composition, has
a very high affinity to the specific inhibitor, ouabain. This is
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Figure 2 | Effect of ouabain, 10mmol/l, on Naþ ,Kþ -ATPase
activity in the parathyroids. 86Rb uptake by the parathyroid
glands was used as an index of Naþ ,Kþ -ATPase-mediated active
Naþ–Kþ transport. The parathyroid glands were incubated for
30min in Krebs–Ringer bicarbonate solution containing 1.0 mCi/ml
86Rb. The 86Rb uptake was significantly decreased in ouabain-
treated than in vehicle-treated parathyroid glands, Po0.001.
Mean±s.e.m., n¼ 18 glands (9 rats) in each group. CPM, counts
per minute; 86Rb, 86rubidium.
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systemic effect, inducing a significant increase in plasma Kþ
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true except for some rodent species, mainly the rat, in which
pumps containing the a1-isoform have a relatively low affinity
for cardiac glycosides.30
However, the important observation is that in the present
investigation, in an in vivo model, no effect of ouabain was
observed on the PTH-secretory response to hypocalcemia,
despite significant inhibition of the pump activity, as shown
by the inhibited 86Rb uptake by the parathyroid glands, when
ouabain was applied.
We have previously found an increased parathyroid
expression of the Naþ ,Kþ -ATPase together with an
increased expression of klotho in severe hyperparathyroid-
ism, secondary to uremia and hyperphosphatemia in the
rat.19 Therefore this investigation was conducted with the
expectation that the Naþ ,Kþ -ATPase might be of relevance
for enhanced PTH secretion in uremia. However, the present
results do not support such a mechanism.
Conclusion
Inhibition of the parathyroid gland Naþ ,Kþ -ATPase
activity had no effect in vivo on the PTH-secretory response
to acute hypocalcemia in the rat. Thus, the previously
suggested importance of the Naþ ,Kþ -ATPase in the
regulation of PTH secretion could not be confirmed in the
present in vivo rat model.
MATERIALS AND METHODS
Animals
The experimental studies were performed in accordance with the
Danish law and approved by the Ministry of Justice. Inbred male
dark auguti rats, weighing 250 g (Taconic A/S, Ejby, Denmark) were
used. Rats were fed a standard diet (0.9% calcium, 0.7%
phosphorus, and vitamin D, 1000 IU/kg), with free access to food
and water. They were kept in a controlled environment in a 12-h
light–dark cycle, constant temperature (of 22 1C), and relative
humidity (70%). The total number of rats amounted to 92. Rats
received anesthesia with pentobarbital (50mg/kg; Nycomed-DAK,
Copenhagen, Denmark), intraperitoneally. Additional doses were
administered, when required, to maintain a steady level of
anesthesia.
Induction of hypocalcemia by infusion of EGTA
Hypocalcemia was induced by intravenous infusion of EGTA
(30mmol/l; Sigma-Aldrich, St Louis, MO), at a rate of 3.0ml/h for
60min through a catheter inserted into the femoral vein. The method
has been described elsewhere.31–33 Samples for determination of plasma
PTH, Ca2þ , Naþ , and Kþ concentrations were obtained from a
corresponding catheter in the femoral artery at 0, 5, and every 10min.
Each time a blood sample was taken, the blood volume was replaced by
an intravenous administration of 0.4ml saline.
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Figure 4 | Effect of potassium on low Ca2þ -stimulated PTH
secretion in vivo. As the application of ouabain on the
parathyroids increased plasma Kþ , the effect of potassium on low
Ca2þ -stimulated PTH secretion in vivo was studied by an
intravenous infusion of 300mmol/l KCl as compared with the
effect of isotonic NaCl administered for 30min, followed by an
EGTA infusion. Plasma Kþ levels were significantly increased
(Po0.001) by the KCl infusion. An increase in plasma Kþ had no
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n¼ 8 in each group. EGTA, ethylene glycol tetraacetic acid; PTH,
parathyroid hormone.
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Application of ouabain
The parathyroid glands were exposed and treated in situ25 with ouabain
(C29H44O12-8 H2O; Sigma-Aldrich, St Louis, MO), a specific inhibitor of
the Naþ ,Kþ -ATPase or vehicle. All procedures were performed by
microsurgery using a stereomicroscope. A microscopic nest of cotton was
built and applied over the parathyroid gland. A volume of 1ml ouabain
or vehicle was then placed over the nest and renewed every 10min.
86Rb uptake
The uptake of 86Rb (Perkin-Elmer Life and Analytical Sciences,
Boston, MA) by the parathyroid glands and the inhibition of the
uptake by ouabain were used as a measure of Naþ ,Kþ -ATPase-
mediated active sodium–potassium transport.
Two parathyroid glands from either ouabain-exposed rats or
vehicle-exposed control rats were incubated separately for 30min at
30 1C in 250 ml of Krebs–Ringer bicarbonate solution (Sigma-
Aldrich) in Corning Costar Transwell Polycarbonate Inserts (Fisher
Scientific, Slangerup, Denmark), containing 1.0 mCi/ml 86Rb. To
remove 86Rb from the extracellular space, the glands were then
washed 4 15min in 1ml of an ice-cold sodium-free Tris
(10mmol/l)-sucrose (250mmol/l) buffer (from Sigma-Aldrich).
After washing, the glands were transferred to counting vials,
containing 2ml 5% trichloroacetic acid, and then radioactivity
was measured in a b-counter after adding 2.5ml Ultima Gold
(Perkin-Elmer Life and Analytical Sciences, Waltham, MA).29 As the
parathyroid glands of inbred DA rats had identical size, the results
are presented as c.p.m. (counts per minute) per gland.
Experimental protocols
Effect of ouabain, 2mmol/l, on low Ca2þ -stimulated PTH
secretion in vivo. The parathyroid glands were exposed and
treated in situ25 with ouabain (2mmol/l) or vehicle for 45min
before and for another 60min, during induction of hypocalcemia by
an EGTA infusion (n¼ 19 in each group).
Effect of ouabain, 10mmol/l, on low Ca2þ -stimulated PTH
secretion in vivo. The parathyroid glands were exposed and treated
in situ with ouabain (10mmol/l) or vehicle (n¼ 19 in each group) for
120min before and for another 50min during EGTA infusion.
The parathyroids were then removed and inhibition of the
Naþ ,Kþ -ATPase was examined by 86Rb uptake (n¼ 9).
Effect of potassium on low Ca2þ -stimulated PTH secretion
in vivo. Intravenous infusion of 300mmol/l KCl or isotonic NaCl
(3ml/h) was performed for 30min, followed by an EGTA infusion
(n¼ 8). Samples for plasma PTH, Ca2þ , Naþ , and Kþ were
obtained every 10min.
Plasma determinations
Plasma phosphate, urea, and creatinine were analyzed using Vitros 250
(Ortho-Clinical Diagnostics, Rochester, NY). Plasma Ca2þ , Naþ , and
Kþ were measured by ABL 505 (Radiometer, Denmark). Plasma PTH
was measured by a rat-bioactive intact PTH ELISA (enzyme-linked
immunosorbent assay) (Immunotopics, San Clemente, CA).31
Statistics
Student’s t-test or Mann–Whitney test and ANOVA (analysis of
variance) with Bonferroni’s posttest were used and data are presented
as mean±s.e.m. Po0.05 was considered statistically significant.
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